BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Karavias DD, Tepetes K, Karatzas T, Felekouras E, Androulakis J. Liver resection for metastatic non-colorectal non-neuroendocrine hepatic neoplasms. Eur J Surg Oncol. 2002;28:135-139. [PMID: 11884048 DOI: 10.1053/ejso.2001.1221] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Pekmezci S, Saribeyoglu K, Aytac E, Arvas M, Demirkiran F, Ozguroglu M. Surgery for isolated liver metastasis of ovarian cancer. Asian J Surg 2010;33:83-8. [PMID: 21029944 DOI: 10.1016/S1015-9584(10)60014-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
2 Ramacciato G, D'angelo F, Baldini R, Petrucciani N, Antolino L, Aurello P, Nigri G, Bellagamba R, Pezzoli F, Balesh A, Cucchetti A, Cescon M, Gaudio MD, Ravaioli M, Pinna AD. Hepatocellular Carcinomas and Primary Liver Tumors as Predictive Factors for Postoperative Mortality after Liver Resection: A Meta-Analysis of More than 35,000 Hepatic Resections. The American Surgeon 2012;78:456-67. [DOI: 10.1177/000313481207800438] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
3 Yoo TG, Cranshaw I, Broom R, Pandanaboyana S, Bartlett A. Systematic review of early and long-term outcome of liver resection for metastatic breast cancer: Is there a survival benefit? The Breast 2017;32:162-72. [DOI: 10.1016/j.breast.2017.02.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
4 Lv Y, Huang C, Xu H, Han X, Zhang L, Mao W, Ji Y, Jin D, Lou W, Xu X. Clinicopathological Characteristics of the primary and metastatic Hepatic Neuroendocrine Tumors and the relevant Prognosis-Related Factors: A Retrospective Study of 81 Cases in a Single Chinese Center. J Cancer. 2018;9:479-487. [PMID: 29483952 DOI: 10.7150/jca.22157] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
5 Howlader M, Heaton N, Rela M. Resection of liver metastases from breast cancer: Towards a management guideline. International Journal of Surgery 2011;9:285-91. [DOI: 10.1016/j.ijsu.2011.01.009] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 2.4] [Reference Citation Analysis]
6 Groeschl RT, Nachmany I, Steel JL, Reddy SK, Glazer ES, de Jong MC, Pawlik TM, Geller DA, Tsung A, Marsh JW, Clary BM, Curley SA, Gamblin TC. Hepatectomy for Noncolorectal Non-Neuroendocrine Metastatic Cancer: A Multi-Institutional Analysis. Journal of the American College of Surgeons 2012;214:769-77. [DOI: 10.1016/j.jamcollsurg.2011.12.048] [Cited by in Crossref: 87] [Cited by in F6Publishing: 78] [Article Influence: 8.7] [Reference Citation Analysis]
7 Joyce DD, Psutka SP, Groeschl RT, Thompson RH, Boorjian SA, Cheville JC, Stewart-merrill SB, Lohse CM, Costello BA, Que FG, Leibovich BC. Complications and Outcomes Associated With Surgical Management of Renal Cell Carcinoma Involving the Liver: A Matched Cohort Study. Urology 2017;99:155-61. [DOI: 10.1016/j.urology.2016.08.015] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
8 Hatzaras I, Gleisner AL, Pulitano C, Sandroussi C, Hirose K, Hyder O, Wolfgang CL, Aldrighetti L, Crawford M, Choti MA, Pawlik TM. A multi-institution analysis of outcomes of liver-directed surgery for metastatic renal cell cancer. HPB (Oxford). 2012;14:532-538. [PMID: 22762401 DOI: 10.1111/j.1477-2574.2012.00495.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 3.5] [Reference Citation Analysis]
9 Kassahun WT. Controversies in defining prognostic relevant selection criteria that determine long-term effectiveness of liver resection for noncolorectal nonneuroendocrine liver metastasis. International Journal of Surgery 2015;24:85-90. [DOI: 10.1016/j.ijsu.2015.11.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
10 Chatzizacharias NA, Rosich-Medina A, Dajani K, Harper S, Huguet E, Liau SS, Praseedom RK, Jah A. Surgical management of hepato-pancreatic metastasis from renal cell carcinoma. World J Gastrointest Oncol 2017; 9(2): 70-77 [PMID: 28255428 DOI: 10.4251/wjgo.v9.i2.70] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
11 Earle SA, Perez EA, Gutierrez JC, Sleeman D, Livingstone AS, Franceschi D, Levi JU, Robbins C, Koniaris LG. Hepatectomy enables prolonged survival in select patients with isolated noncolorectal liver metastasis. J Am Coll Surg. 2006;203:436-446. [PMID: 17000386 DOI: 10.1016/j.jamcollsurg.2006.06.031] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 2.4] [Reference Citation Analysis]
12 Langan RC, Ripley RT, Davis JL, Prieto PA, Datrice N, Steinberg SM, Bratslavsky G, Rudloff U, Kammula US, Stojadinovic A. Liver directed therapy for renal cell carcinoma. J Cancer. 2012;3:184-190. [PMID: 22558019 DOI: 10.7150/jca.4456] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
13 Costa SRP, Horta SH, Henriques AC, Waisberg J, Speranzini MB. Hepatectomia para o tratamento de metástases colorretais e não-colorretais: análise comparativa em 30 casos operados. Rev bras colo-proctol 2009;29:216-25. [DOI: 10.1590/s0101-98802009000200009] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
14 Aloia TA, Adam R, Azoulay D, Bismuth H, Castaing D. Outcome following hepatic resection of metastatic renal tumors: the Paul Brousse Hospital experience. HPB (Oxford). 2006;8:100-105. [PMID: 18333255 DOI: 10.1080/13651820500496266] [Cited by in Crossref: 40] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
15 Delaunoit T, Neczyporenko F, Limburg PJ, Erlichman C. Small Bowel Adenocarcinoma: A Rare but Aggressive Disease. Clinical Colorectal Cancer 2004;4:241-8. [DOI: 10.3816/ccc.2004.n.023] [Cited by in Crossref: 18] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Thelen A, Jonas S, Benckert C, Lopez-Hänninen E, Rudolph B, Neumann U, Neuhaus P. Liver resection for metastases from renal cell carcinoma. World J Surg. 2007;31:802-807. [PMID: 17354021 DOI: 10.1007/s00268-007-0685-9] [Cited by in Crossref: 59] [Cited by in F6Publishing: 43] [Article Influence: 3.9] [Reference Citation Analysis]
17 Weitz J, Blumgart LH, Fong Y, Jarnagin WR, D'Angelica M, Harrison LE, DeMatteo RP. Partial hepatectomy for metastases from noncolorectal, nonneuroendocrine carcinoma. Ann Surg. 2005;241:269-276. [PMID: 15650637 DOI: 10.1097/01.sla.0000150244.72285.ad] [Cited by in Crossref: 142] [Cited by in F6Publishing: 118] [Article Influence: 8.4] [Reference Citation Analysis]
18 de Ridder J, van Walsum M, Verhoef C, Nagtegaal I, de Wilt J. Hepatic resection for metastatic melanoma in The Netherlands: survival and prognostic factors. Melanoma Research 2013;23:27-32. [DOI: 10.1097/cmr.0b013e32835b70c8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
19 Alves A, Adam R, Majno P, Delvart V, Azoulay D, Castaing D, Bismuth H. Hepatic resection for metastatic renal tumors: is it worthwhile? Ann Surg Oncol. 2003;10:705-710. [PMID: 12839857 DOI: 10.1245/aso.2003.07.024] [Cited by in Crossref: 84] [Cited by in F6Publishing: 25] [Article Influence: 4.4] [Reference Citation Analysis]
20 O'Rourke TR, Tekkis P, Yeung S, Fawcett J, Lynch S, Strong R, Wall D, John TG, Welsh F, Rees M. Long-term results of liver resection for non-colorectal, non-neuroendocrine metastases. Ann Surg Oncol. 2008;15:207-218. [PMID: 17963007 DOI: 10.1245/s10434-007-9649-4] [Cited by in Crossref: 66] [Cited by in F6Publishing: 56] [Article Influence: 4.4] [Reference Citation Analysis]
21 Kim VM, Goicochea L, Fang SH. Case Report: Collision Tumour of Colon Leiomyosarcoma and Adenocarcinoma. J ClinDiagn Res. 2016;10:PD03-PD04. [PMID: 27504346 DOI: 10.7860/jcdr/2016/16949.7956] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
22 Fitzgerald TL, Brinkley J, Banks S, Vohra N, Englert ZP, Zervos EE. The benefits of liver resection for non-colorectal, non-neuroendocrine liver metastases: a systematic review. Langenbecks Arch Surg. 2014;399:989-1000. [PMID: 25148767 DOI: 10.1007/s00423-014-1241-3] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 4.4] [Reference Citation Analysis]
23 Adam R, Chiche L, Aloia T, Elias D, Salmon R, Rivoire M, Jaeck D, Saric J, Le Treut YP, Belghiti J. Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1,452 patients and development of a prognostic model. Ann Surg. 2006;244:524-535. [PMID: 16998361 DOI: 10.1097/01.sla.0000239036.46827.5f] [Cited by in Crossref: 31] [Cited by in F6Publishing: 120] [Article Influence: 1.9] [Reference Citation Analysis]
24 Goéré D, Elias D. Resection of liver metastases from non-colorectal non-endocrine primary tumours. Eur J Surg Oncol 2008;34:281-8. [PMID: 17933487 DOI: 10.1016/j.ejso.2007.07.205] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
25 Melichar B, Vobořil Z, Nožička J, Cerman J, Melicharová K, Mergancová J, Filip S, Krajina A, Vobořil R, Jandík P. Hepatic Arterial Infusion Chemotherapy in Sarcoma Liver Metastases: A Report of 6 Cases. Tumori 2005;91:19-23. [DOI: 10.1177/030089160509100105] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
26 Yedibela S, Gohl J, Graz V, Pfaffenberger MK, Merkel S, Hohenberger W, Meyer T. Changes in indication and results after resection of hepatic metastases from noncolorectal primary tumors: a single-institutional review. Ann Surg Oncol. 2005;12:778-785. [PMID: 16132374 DOI: 10.1245/aso.2005.11.018] [Cited by in Crossref: 63] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
27 Uggeri F, Ronchi PA, Goffredo P, Garancini M, Degrate L, Nespoli L, Gianotti L, Romano F. Metastatic liver disease from non-colorectal, non-neuroendocrine, non-sarcoma cancers: a systematic review. World J Surg Oncol 2015;13:191. [PMID: 26022107 DOI: 10.1186/s12957-015-0606-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
28 Bohlok A, Lucidi V, Bouazza F, Daher A, Germanova D, Van Laethem JL, Hendlisz A, Donckier V. The lack of selection criteria for surgery in patients with non-colorectal non-neuroendocrine liver metastases. World J Surg Oncol 2020;18:106. [PMID: 32450872 DOI: 10.1186/s12957-020-01883-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Stavrou GA, Flemming P, Oldhafer KJ. Liver resection for metastasis due to malignant mesenchymal tumours. HPB (Oxford) 2006;8:110-3. [PMID: 18333257 DOI: 10.1080/13651820500472143] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
30 Poon RT, Fan ST, Lo CM, Liu CL, Lam CM, Yuen WK, Yeung C, Wong J. Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database. Ann Surg. 2004;240:698-708; discussion 708-10. [PMID: 15383797 DOI: 10.1097/01.sla.0000141195.66155.0c] [Cited by in Crossref: 162] [Cited by in F6Publishing: 286] [Article Influence: 9.0] [Reference Citation Analysis]